24.65
+0.18
+(0.74%)
At close: April 17 at 4:00:01 PM EDT
24.74
+0.09
+(0.37%)
After hours: April 17 at 5:01:22 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
189,389
189,389
154,649
145,274
125,717
Investing Cash Flow
-83,276
-83,276
77,541
-225,185
-20,790
Financing Cash Flow
17,363
17,363
-183,031
-401,528
380,694
End Cash Position
276,774
276,774
153,298
104,139
585,578
Income Tax Paid Supplemental Data
11,021
11,021
4,366
7,398
3,221
Interest Paid Supplemental Data
15,418
15,418
27,635
33,295
6,996
Capital Expenditure
-10,636
-10,636
-15,161
-30,076
-45,866
Issuance of Debt
287,500
287,500
149,550
--
363,750
Repayment of Debt
-210,885
-210,885
-330,312
-427,694
--
Repurchase of Capital Stock
-25,000
-25,000
--
--
--
Free Cash Flow
178,753
178,753
139,488
115,198
79,851
12/31/2021 - 2/3/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
COLL Collegium Pharmaceutical, Inc.
27.01
-0.04%
ANIP ANI Pharmaceuticals, Inc.
69.21
+0.01%
SUPN Supernus Pharmaceuticals, Inc.
30.76
+0.16%
KNSA Kiniksa Pharmaceuticals International, plc
20.21
-1.58%
IRWD Ironwood Pharmaceuticals, Inc.
0.7267
-3.11%
NBIX Neurocrine Biosciences, Inc.
101.38
+1.28%
AVDL Avadel Pharmaceuticals plc
8.03
-1.47%
HCM HUTCHMED (China) Limited
13.76
+0.15%
INDV Indivior PLC
9.01
-0.55%
AMRX Amneal Pharmaceuticals, Inc.
7.36
+2.51%